Immediate Impact

1 from Science/Nature 50 hit
Sub-graph 1 of 25

Citing Papers

Small Cell Lung Cancer
2025 Hit
Resistance mechanisms to immune checkpoint inhibitors: updated insights
2025 Hit
2 intermediate papers

Works of Efisio Defraia being referenced

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
2017

Author Peers

Author Last Decade Papers Cites
Efisio Defraia 754 419 366 321 287 55 1.2k
Sanjay M. Mallya 319 215 554 298 261 72 1.4k
W.A.M. van der Kwast 332 364 437 85 100 30 1.1k
Juhani Wolf 218 145 704 169 91 52 1.4k
Fábio Lourenço Romano 551 86 291 192 94 106 1.0k
Ahmet Ercan Şekerci 319 142 774 293 328 72 1.2k
Chiung‐Shing Huang 357 171 211 264 709 47 1.4k
Sheldon Mintz 149 67 415 132 183 66 1.0k
Maria Alves Garcia Silva 331 151 619 127 71 45 988
Jonas P. Becktor 392 68 878 203 172 55 1.2k
F.J. Rodríguez-Campo 113 267 264 104 116 59 1.4k

All Works

Loading papers...

Rankless by CCL
2026